Transcription factors related to epithelial mesenchymal transition in tumor center and margin in invasive lung adenocarcinoma

Young-In Maeng; Kyung-Hyun Kim; Jung-Yeon Kim; Sun-Jae Lee; Woo-Jung Sung; Chong-Kee Lee; Jae-Bok Park; Kwan-Kyu Park
July 2014
International Journal of Clinical & Experimental Pathology;2014, Vol. 7 Issue 7, p4095
Academic Journal
No abstract available.


Related Articles

  • C/EBPα Suppresses Lung Adenocarcinoma Cell Invasion and Migration by Inhibiting β-Catenin. Lu, Jinchang; Du, Chunling; Yao, Junxia; Wu, Bo; Duan, Yanhong; Zhou, Lei; Xu, Donghui; Zhou, Feng; Gu, Liang; Zhou, Hong; Sun, Yingxin // Cellular Physiology & Biochemistry (Karger AG);Oct2017, Vol. 42 Issue 5, p1779 

    Background/Aims: The transcription factor CCAAT/enhancer-binding protein a (C/EBPα) is a basic leucine zipper transcription factor that plays essential roles in tumor progression. Although decreased or absent C/EBPα expression in many cancers suggests a possible role for C/EBPα as a...

  • ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism. Yanan Yang; Young-Ho Ahn; Yulong Chen; Xiaochao Tan; Lixia Guo; Gibbons, Don L.; Ungewiss, Christin; Peng, David H.; Xin Liu; Lin, Steven H.; Thilaganathan, Nishan; Wistuba, Ignacio I.; Rodriguez-Canales, Jaime; McLendon, Georgia; Creighton, Chad J.; Kurie, Jonathan M. // Journal of Clinical Investigation;Jun2014, Vol. 124 Issue 6, p2696 

    Epithelial tumor cells that have undergone epithelial-to-mesenchymal transition (EMT) are typically prone to metastasis and drug resistance and contribute to a poor clinical outcome. The transcription factor ZEB1 is a known driver of EMT, and mediators of ZEB1 represent potential therapeutic...

  • The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. Yanan Yang; Young-Ho Ahn; Gibbons, Don L.; Vi Zang; Wei Lin; Thilaganathan, Nishan; Alvarez, Cristina A.; Moreira, Daniel C.; Creighton, Chad J.; Gregory, Philip A.; Goodall, Gregory J.; Kurie, Jonathan M. // Journal of Clinical Investigation;Apr2011, Vol. 121 Issue 4, p1373 

    Epithelial tumor cells transit to a mesenchymal state in response to extracellular cues, in a process known as epithelial-to-mesenchymal transition (EMT). The precise nature of these cues has not been fully defined, an important issue given that EMT is an early event in tumor metastasis. Here,...

  • Expression of Transforming Growth Factor β1 and Cadherins in Lung Adenocarcinoma. Sonya Youngju Park; Jinyoung Yoo // Journal of Lung Cancer;Jun2012, Vol. 11 Issue 1, p38 

    Purpose: There is evidence supporting the concept of tumor progression from pulmonary adenocarcinoma in situ (formerly bronchioloalveolar carcinoma, BAC) to adenocarcinoma with varying degrees of invasion. The aim of this study was to investigate the role of transforming growth factor β1...

  • The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells. Fernando, Romaine I.; Litzinger, Mary; Trono, Paola; Hamilton, Duane H.; Schlom, Jeffrey; Palena, Claudia // Journal of Clinical Investigation;Feb2010, Vol. 120 Issue 2, p533 

    Metastatic disease is responsible for the majority of human cancer deaths. Understanding the molecular mechanisms of metastasis is a major step in designing effective cancer therapeutics. Here we show that the T-box transcription factor Brachyury induces in tumor cells epithelial-mesenchymal...

  • Activation of NF-κB by SOD2 promotes the aggressiveness of lung adenocarcinoma by modulating NKX2-1-mediated IKKβ expression. Chen, Po-Ming; Wu, Tzu-Chin; Wang, Yao-Chen; Cheng, Ya-Wen; Sheu, Gwo-Tarng; Chen, Chih-Yi; Lee, Huei // Carcinogenesis;Nov2013, Vol. 34 Issue 11, p2655 

    Magnesium superoxide dismutase (SOD2) has been shown to cause dysfunction of p53 transcriptional activity, whereas, in turn, SOD2 expression is regulated by p53 to modulate lung tumorigenesis. In this study, we found that the level of SOD2 expression in a panel of lung cancer cells was...

  • Research Advance on Mechanism and Application of HATs and HDACs in Epithelial-Mesenchymal Transition of Lung Cancer. Rui CHANG; Jiacong YOU; Qinghua ZHOU // Chinese Journal of Lung Cancer;Apr2013, Vol. 16 Issue 4, p211 

    Lung cancer is one of the most common diseases that endanger health and life of people domestically. A number of recurrence and death of lung cancer originated from metastasis. As a key step in metastasis of lung cancer, epithelial to mesenchymal transition involved down-regulation of...

  • CC-Chemokine Ligand 18 Induces Epithelial to Mesenchymal Transition in Lung Cancer A549 Cells and Elevates the Invasive Potential. Ploenes, Till; Scholtes, Ben; Krohn, Alexander; Burger, Meike; Passlick, Bernward; Müller-Quernheim, Joachim; Zissel, Gernot // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    Lung cancer is one of the leading causes of cancer related death worldwide with more than a million deaths per year. The poor prognosis is due to its high aggressiveness and its early metastasis. Although the exact mechanisms are still unknown, the process of epithelial to mesenchymal transition...

  • Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients. Sang-Jeon Lee; Song Yi Choi; Wun-Jae Kim; Meiying Ji; Taek-Gu Lee; Bo-Ra Son; Soon Man Yoon; Rohyun Sung; Eun Jeoung Lee; Sei Jin Youn; Seon Mee Park // Diagnostic Pathology;2013, Vol. 8 Issue 1, p1 

    Background/Aims: Epithelial-to-mesenchymal transition (EMT) in cancers is related to metastasis, recurrence, and poor prognosis. We evaluated whether EMT-related proteins can act as prognostic biomarkers in colorectal cancer (CRC) patients. Methods: We evaluated the expression of E-cadherin,...

  • Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer. Shen, Liqin; Chen, Lei; Wang, Yongsheng; Jiang, Xiaochun; Xia, Hongping; Zhuang, Zhixiang // Journal of Neuro-Oncology;Jan2015, Vol. 121 Issue 1, p101 

    Brain metastasis often has a poor prognosis in patients with advanced non-small cell lung cancer (NSCLC). Therefore, it is urgent to identify factors associated with lung cancer brain metastasis. Metastasis associated lung adenocarcinoma transcript 1 (MALAT1) also known as noncoding...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics